期刊
NATURE REVIEWS CLINICAL ONCOLOGY
卷 9, 期 6, 页码 312-313出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2012.76
关键词
-
类别
The benefit of salvage chemotherapy in gastric cancer refractory to first-line platinum and fluoropyrimidine therapy was previously unknown. A randomized multicentre study has shown that irinotecan or docetaxel administered as single agents improved survival compared with best supportive care alone. Hence, salvage chemotherapy is now a proven option in pretreated gastric cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据